Article
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.
Journal of medical virology - 1 Dec 1993
Balboni P G, Bozzini R, Zucchini S, Marconi P C, Grossi M P, Caputo A, Manservigi R, Barbanti-Brodano G
Abstract excerpt
A BK virus (BKV) expression vector, specific for human cells, was engineered to express antisense human immunodeficiency virus type 1 (HIV-1) tat cDNA (tat-AS) or a tat mutant in cysteine 22 (tat22). Cysteine residues in the cysteine-rich domain of tat are necessary for tat transactivation of the HIV-1 long terminal repeat (LTR). Both the AS tat and the tat mutant significantly inhibited transactivation by tat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
